Application Effect of Comprehensive Noise Reduction Technology in Outpatients with Vitiligo: A Retrospective Study
CONCLUSION: The investigation and data analysis demonstrated that comprehensive noise reduction in outpatients with vitiligo had a considerable effect. This technology can standardise the behaviour of medical staff, enhance nursing quality, reduce noise levels and alleviate patients' anxiety and improve their satisfaction. It has great benefits for the outpatient environment and patients.PMID:38570309 | DOI:10.4103/nah.nah_60_23 (Source: Noise and Health)
Source: Noise and Health - April 3, 2024 Category: Audiology Authors: Yong Liu Jingjing Wang Jianli Huo Shaoguang Zhang Li Han Yong Lei Ya'nan Wang Source Type: research

Application Effect of Comprehensive Noise Reduction Technology in Outpatients with Vitiligo: A Retrospective Study
CONCLUSION: The investigation and data analysis demonstrated that comprehensive noise reduction in outpatients with vitiligo had a considerable effect. This technology can standardise the behaviour of medical staff, enhance nursing quality, reduce noise levels and alleviate patients' anxiety and improve their satisfaction. It has great benefits for the outpatient environment and patients.PMID:38570309 | DOI:10.4103/nah.nah_60_23 (Source: Noise and Health)
Source: Noise and Health - April 3, 2024 Category: Audiology Authors: Yong Liu Jingjing Wang Jianli Huo Shaoguang Zhang Li Han Yong Lei Ya'nan Wang Source Type: research

Autoimmune Liver Disease Associated Uveitis: An Extrahepatic Manifestation or a Polyautoimmunity Phenomenon? Case Reports
CONCLUSIONS: Uveitis rarely coexists with ALD. However, it is essential to recognize the possibility of polyautoimmunity in patients presenting with ophthalmic manifestations and a previous diagnosis of ALD, such as PSC or PBC.PMID:38564673 | DOI:10.1080/09273948.2024.2333391 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 2, 2024 Category: Allergy & Immunology Authors: Laura Zarate-Pinz ón Gabriela Fl órez-Esparza Camilo Andr és Rodríguez-Rodríguez Luis A Diez-Baham ón Germ án Mejía-Salgado Carlos Cifuentes-Gonz ález Alejandra de-la-Torre Source Type: research

30. Comparison of Signs & Symptoms among Pediatric Patients with Lichen Sclerosis (LS) & Vitiligo: Preliminary Findings from an Interdisciplinary Vulvar Dermatology Clinic
Differentiating pediatric vulvar lichen sclerosis versus vitiligo is a clinical challenge. For both conditions, patients often have a delayed or initial misdiagnosis. Both conditions classically present with hypopigmentation, while LS is more likely to present with symptoms such as pruritus, bleeding, and pain. We aim to add to the existing literature by comparing signs and symptoms in a cohort of patients with either conditions. (Source: Journal of Pediatric and Adolescent Gynecology)
Source: Journal of Pediatric and Adolescent Gynecology - April 1, 2024 Category: OBGYN Authors: Kirsten Das, Mary Solimon, Swetha Naroji, Kaiane Habeshian, Veronica Gomez-Lobo Source Type: research

Burden of Disease and Treatment Patterns Amongst Patients With Vitiligo: Findings From a National, Longitudinal Retrospective Study in the United Kingdom
Br J Dermatol. 2024 Mar 27:ljae133. doi: 10.1093/bjd/ljae133. Online ahead of print.ABSTRACTThis retrospective study, using UK Clinical Practice Research Datalink and Hospital Episode Statistics databases, analysed 17,239 incident patients with vitiligo. Mean incidence of vitiligo was 0.16 (2010-2021) per 1000 person-years (range: 0.10 [2010-COVID] to 0.19 [2013/2018]); prevalence increased from 0.21% (2010) to 0.38% (2021). The most common comorbidities recorded after vitiligo diagnosis were diabetes (19.4%), eczema (8.9%), thyroid disease (7.5%), and rheumatoid arthritis (6.9%). Mental health diagnoses recorded at any ti...
Source: The British Journal of Dermatology - March 27, 2024 Category: Dermatology Authors: Viktoria Eleftheriadou Carine Delattre Shala Chetty-Mhlanga Christopher Lee Laura Girardat-Rotar Iftekhar Khan Amit Mathew Andrew R Thompson Source Type: research

Burden of Disease and Treatment Patterns Amongst Patients With Vitiligo: Findings From a National, Longitudinal Retrospective Study in the United Kingdom
Br J Dermatol. 2024 Mar 27:ljae133. doi: 10.1093/bjd/ljae133. Online ahead of print.ABSTRACTThis retrospective study, using UK Clinical Practice Research Datalink and Hospital Episode Statistics databases, analysed 17,239 incident patients with vitiligo. Mean incidence of vitiligo was 0.16 (2010-2021) per 1000 person-years (range: 0.10 [2010-COVID] to 0.19 [2013/2018]); prevalence increased from 0.21% (2010) to 0.38% (2021). The most common comorbidities recorded after vitiligo diagnosis were diabetes (19.4%), eczema (8.9%), thyroid disease (7.5%), and rheumatoid arthritis (6.9%). Mental health diagnoses recorded at any ti...
Source: The British Journal of Dermatology - March 27, 2024 Category: Dermatology Authors: Viktoria Eleftheriadou Carine Delattre Shala Chetty-Mhlanga Christopher Lee Laura Girardat-Rotar Iftekhar Khan Amit Mathew Andrew R Thompson Source Type: research

Is vitiligo associated with an increased risk of cardiovascular outcomes? Perceptions from a population-based study
Australas J Dermatol. 2024 Mar 25. doi: 10.1111/ajd.14251. Online ahead of print.NO ABSTRACTPMID:38528737 | DOI:10.1111/ajd.14251 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - March 26, 2024 Category: Dermatology Authors: Khalaf Kridin Niv Kafri Arnon D Cohen Source Type: research

Is vitiligo associated with an increased risk of cardiovascular outcomes? Perceptions from a population-based study
Australas J Dermatol. 2024 Mar 25. doi: 10.1111/ajd.14251. Online ahead of print.NO ABSTRACTPMID:38528737 | DOI:10.1111/ajd.14251 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - March 26, 2024 Category: Dermatology Authors: Khalaf Kridin Niv Kafri Arnon D Cohen Source Type: research

Is vitiligo associated with an increased risk of cardiovascular outcomes? Perceptions from a population-based study
Australas J Dermatol. 2024 Mar 25. doi: 10.1111/ajd.14251. Online ahead of print.NO ABSTRACTPMID:38528737 | DOI:10.1111/ajd.14251 (Source: The Australasian Journal of Dermatology)
Source: The Australasian Journal of Dermatology - March 26, 2024 Category: Dermatology Authors: Khalaf Kridin Niv Kafri Arnon D Cohen Source Type: research

Correlating Cicatricial Alopecia and Cardiovascular Risk: Emerging Insights
The recent study published in this journal entitled “Association of Primary Cicatricial Alopecia with Subsequent Cardiovascular Disease” (Kim et al., 2023) adds new insights on the complex link between chronic inflammation of epithelial tissues and increased cardiovascular (CV) risk in patients with hair disorders. Primary Cicatricial Alopecia ( PCA) might not only be a dermatological condition, as systemic associations including autoimmune disorders such as thyroid diseases and vitiligo, metabolic syndrome, and, notably, CV risk can be part of the disease. (Source: Journal of Investigative Dermatology)
Source: Journal of Investigative Dermatology - March 26, 2024 Category: Dermatology Authors: Andrea Sechi, Antonella Tosti Tags: Commentary Source Type: research

A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
This report presents a unique case of a vitiligo patient with concomitant systemic lupus erythematosus. Remarkably, after a 30-day course of treatment with tofacitinib, complete repigmentation of the white macular rash was achieved, and there were no adverse drug reactions. These findings provide compelling evidence for the efficacy and safety of oral JAK inhibitors, such as tofacitinib, in vitiligo treatment. Additionally, JAK inhibitors can yet be regarded as a promising new treatment option for vitiligo patients with concurrent autoimmune diseases.PMID:38524393 | PMC:PMC10961069 | DOI:10.2147/CCID.S448535 (Source: Clini...
Source: Clinical, Cosmetic and Investigational Dermatology - March 25, 2024 Category: Dermatology Authors: Qingxia Lin Jinrong Zhu Xuelei Gao Source Type: research

Human Mesenchymal Stem Cell-Derived Exosomes Promote the Proliferation and Melanogenesis of Primary Melanocytes by Attenuating the H < sub > 2 < /sub > O < sub > 2 < /sub > -Related Cytotoxicity in vitro
CONCLUSION: Our findings indicate that treatment with a low dose of MSC-Exo promotes the proliferation and melanogenesis of human primary melanocytes by ameliorating the H2O2-induced apoptosis and senescence of melanocytes. MSC-Exo may be a promising therapeutic strategy of vitiligo.PMID:38524392 | PMC:PMC10959324 | DOI:10.2147/CCID.S446676 (Source: Clinical, Cosmetic and Investigational Dermatology)
Source: Clinical, Cosmetic and Investigational Dermatology - March 25, 2024 Category: Dermatology Authors: Yexiao Wang Zibin He Bingqin Luo Hioteng Wong Liangcai Wu Hui Zhou Source Type: research

A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
This report presents a unique case of a vitiligo patient with concomitant systemic lupus erythematosus. Remarkably, after a 30-day course of treatment with tofacitinib, complete repigmentation of the white macular rash was achieved, and there were no adverse drug reactions. These findings provide compelling evidence for the efficacy and safety of oral JAK inhibitors, such as tofacitinib, in vitiligo treatment. Additionally, JAK inhibitors can yet be regarded as a promising new treatment option for vitiligo patients with concurrent autoimmune diseases.PMID:38524393 | PMC:PMC10961069 | DOI:10.2147/CCID.S448535 (Source: Clini...
Source: Clinical, Cosmetic and Investigational Dermatology - March 25, 2024 Category: Dermatology Authors: Qingxia Lin Jinrong Zhu Xuelei Gao Source Type: research